F, female; M, male; BC, breast cancer; DLBCL, diffuse large B-cell lymphoma; OC, ovarian cancer; NEC, neuroendocrine carcinoma; PC, pancreatic cancer; PEG-G, pegfilgrastim; FIL, filgrastim;  Re-adm, G-CSF at the re-administration; NR, not reported; M, months. This evidence concerns the gene CSF3 and ovarian cancer.